文献速递主动脉外科

胸腹主动脉瘤直径对开窗/分支支架修复结局的影响

The impact of large aneurysm diameter on the outcomes of thoracoabdominal aneurysm repair by fenestrated and branched endografts.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

该多中心回顾性研究分析了247例胸腹主动脉瘤患者,以术前瘤体直径≥80 mm为界值,比较开窗/分支支架修复的结局。结果发现直径≥80 mm未显著影响技术成功率和早期死亡率,但脊髓损伤发生率更高(17% vs 7%,P=0.03),且为再干预和目标内脏血管不稳定的独立危险因素。

要点

  • 术前瘤体直径≥80 mm的患者脊髓损伤发生率显著高于<80 mm者(17% vs 7%,P=0.03)。
  • 直径≥80 mm是再干预的独立危险因素(HR 1.9,95%CI 1.1-3.6,P=0.04)。
  • 直径≥80 mm是目标内脏血管不稳定的独立危险因素(HR 3.1,95%CI 1.3-5.1,P=0.04)。

核心结论

  • 术前胸腹主动脉瘤直径>80 mm对早期技术成功和临床结局无直接影响。
  • 直径≥80 mm是随访期再干预和目标内脏血管不稳定的独立危险因素,但竞争风险分析后无统计学意义。

研究设计与样本

  • 回顾性分析2个欧洲中心2011-2021年接受开窗/分支支架胸腹主动脉修复的247例胸腹主动脉瘤患者。
  • 以瘤体直径第三四分位数80 mm为界值分组比较,中位随访13个月(IQR 2-37)。

主要发现

  • 技术成功率93%(<80 mm组91% vs ≥80 mm组94%,P=0.47)。
  • 3年生存率65%,免于再干预率62%;再干预45例(18%)。

关键数值与推荐

  • 定制分支支架160例(65%),现货分支支架87例(35%)。
  • 多因素分析未将术前直径≥80 mm列为主要终点的显著危险因素。
  • 再干预独立危险因素:术前直径≥80 mm(HR 1.9,95%CI 1.1-3.6,P=0.04)。
  • 目标内脏血管不稳定独立危险因素:术前直径≥80 mm(HR 3.1,95%CI 1.3-5.1,P=0.04)。
  • 竞争风险分析后,术前直径对随访结果无显著影响。

临床怎么用

  • 对于胸腹主动脉瘤直径≥80 mm的患者,应加强随访监测再干预和目标内脏血管不稳定。
  • 术前直径≥80 mm不影响早期技术成功和死亡率,但需警惕脊髓损伤风险升高。

局限性

  • 回顾性研究设计,仅纳入2个欧洲中心,可能存在选择偏倚。
  • 中位随访时间较短(13个月),长期结局需进一步验证。
  • 竞争风险分析后直径≥80 mm对随访结果无显著影响,需谨慎解读独立危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Aim of the study was to analyse the impact of preoperative thoracoabdominal aneurysm diameter on the outcomes of fenestrated/branched endografting. METHODS: Patients who underwent endovascular thoracoabdominal repair at 2 European centres (2011-2021) were analysed. Median diameter was calculated; the third quartile was considered a cut-off. Outcomes were compared in 2 groups based on the diameter value. Primary endpoints were technical success, spinal cord ischaemia and 30-day/in-hospital mortality. Survival, freedom from reintervention and target visceral vessels instability were follow-up outcomes. RESULTS: Out of 247 thoracoabdominal aortic aneurysms, the median diameter was 65 mm, first quartile was 57 mm; third quartile was 80 mm, set as cut-off value. Fifty-nine (24%) patients had diameter ≥80 mm. Custom-made and off-the-shelf branched endograft were used in 160 (65%) and 87 (35%), respectively. Technical success was 93% (<80 mm: 91% vs ≥80 mm: 94%; P = 0.47). Twenty-three (9%) patients had spinal injury (<80 mm: 7% vs ≥80mm: 17%; P = 0.03). Twenty-two (9%) patients died within 30-day/in-hospital (<80 mm: 7% vs ≥80 mm: 15%; P = 0.06). Multivariate analysis did not report preoperative diameter ≥80 mm as significant risk factor for primary endpoints. The median follow-up was 13 (interquartile range: 2-37) months and at 3-year survival and freedom from reintervention rates were 65% and 62%, respectively. After univariate and multivariate analyses, preoperative diameter ≥80 mm was considered an independent risk factor for reinterventions [hazard ratio (HR): 1.9; 95% confidence interval (CI) 1.1-3.6; P = 0.04], and for target visceral vessels instability (HR: 3.1; 95% CI: 1.3-5.1; P = 0.04), occurred in 45 (18%) cases. However, after competing risk methods, preoperative diameter did not show significance for follow-up results. CONCLUSIONS: A preoperative thoracoabdominal aortic aneurysm diameter >80 mm has not had a direct impact on early technical and clinical outcomes. A diameter≥80 mm is considered risk factor for reinterventions and target vessels instability is considered separately during follow-up.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Gallitto E, Tsilimparis N, Spath P, et al. The impact of large aneurysm diameter on the outcomes of thoracoabdominal aneurysm repair by fenestrated and branched endografts. Eur J Cardiothorac Surg. 2024. PMID: 39447039. doi:10.1093/ejcts/ezae387

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。